Prostate Cancer Mortality in the Finnish Randomized Screening Trial

Abstract

At 12 years, a relatively conservative screening protocol produced a small, non-statistically significant PC-specific mortality reduction in the Finnish trial, at the cost of moderate overdiagnosis.